Status:

UNKNOWN

Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Asthma

COPD

Eligibility:

All Genders

18+ years

Brief Summary

The aims of this study are to investigate the association between sputum and plasma levels of nociceptin and substance P with cough severity and airway hyperreactivity in patients with asthma, COPD an...

Detailed Description

Recent animal studies have found that nociceptin can inhibit cough responses induced by capsaicin. We hypothesize that sputum and plasma levels of these peptides may reflect some neurochemical alterat...

Eligibility Criteria

Inclusion

  • patients with asthma, COPD, chronic cough
  • \-

Exclusion

  • patients refusing blood sampling

Key Trial Info

Start Date :

June 1 2005

Trial Type :

OBSERVATIONAL

End Date :

June 1 2005

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00173225

Start Date

June 1 2005

End Date

June 1 2005

Last Update

September 15 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ping-Hung Kuo

Taipei, Taiwan, 100

Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough | DecenTrialz